iBio, Inc. (NYSEMKT:IBIO – Get Free Report) shot up 1.3% during mid-day trading on Monday . The stock traded as high as $3.18 and last traded at $3.01. 243,216 shares changed hands during mid-day trading, an increase of 115% from the average session volume of 113,212 shares. The stock had previously closed at $2.97.
iBio Price Performance
The company has a debt-to-equity ratio of 0.04, a current ratio of 0.91 and a quick ratio of 0.91. The business’s 50-day simple moving average is $2.65 and its two-hundred day simple moving average is $2.38.
iBio Company Profile
iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.
Featured Articles
- Five stocks we like better than iBio
- Quiet Period Expirations Explained
- How to Invest in Small Cap Stocks
- How to Profit From Value Investing
- These Are the Dividend Stocks Insiders Bought in January
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for iBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iBio and related companies with MarketBeat.com's FREE daily email newsletter.
